112 related articles for article (PubMed ID: 38058839)
1. Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapy.
Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA; Hsieh MC
Am J Cancer Res; 2023; 13(11):5504-5512. PubMed ID: 38058839
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
Chen JH; Huang WY; Ho CL; Chao TY; Lee JC
Head Neck; 2019 Nov; 41(11):3775-3782. PubMed ID: 31435974
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
[TBL] [Abstract][Full Text] [Related]
4. Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
Huang WY; Ho CL; Lee CC; Hsiao CW; Wu CC; Jao SW; Yang JF; Lo CH; Chen JH
PLoS One; 2017; 12(3):e0174280. PubMed ID: 28328969
[TBL] [Abstract][Full Text] [Related]
5. Oral tegafur-uracil as a metronomic therapy in stage IVa and IVb cancer of the oral cavity.
Huang WY; Ho CL; Chao TY; Lee JC; Chen JH
Am J Otolaryngol; 2021; 42(6):103156. PubMed ID: 34242883
[TBL] [Abstract][Full Text] [Related]
6. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
8. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
[TBL] [Abstract][Full Text] [Related]
9. Platinum Plus Tegafur-Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis.
Lien CF; Wang CC; Yang CC; Wang CC; Hwang TZ; Shih YC; Yeh SA; Hsieh MC
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139674
[TBL] [Abstract][Full Text] [Related]
10. The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer.
Guo J; Zhang L; Zhang L; Wu J; Xu L; E H; Li C; Wu H; Zhao D; Hu Y; Zhang J; Hu X
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13311-13321. PubMed ID: 37488397
[TBL] [Abstract][Full Text] [Related]
11. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study.
Chen SC; Chang PM; Yang MH
Oncologist; 2016 May; 21(5):537-8. PubMed ID: 27091418
[TBL] [Abstract][Full Text] [Related]
13. The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience.
Yeh TJ; Chan LP; Tsai HT; Hsu CM; Cho SF; Pan MR; Liu YC; Huang CJ; Wu CW; Du JS; Wang HC
Biology (Basel); 2021 Feb; 10(2):. PubMed ID: 33672266
[TBL] [Abstract][Full Text] [Related]
14. Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).
Ohno S; Saji S; Masuda N; Tsuda H; Akiyama F; Kurosumi M; Shimomura A; Sato N; Takao S; Ohsumi S; Tokuda Y; Inaji H; Watanabe T; Ohashi Y
Breast Cancer Res Treat; 2021 Feb; 186(1):135-147. PubMed ID: 33259001
[TBL] [Abstract][Full Text] [Related]
15. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
[TBL] [Abstract][Full Text] [Related]
16. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
Chao JY; Wang HM; Chiang FF; Lin JC; Chang CF; Lin JF; Yeh HL
J Chin Med Assoc; 2014 Mar; 77(3):128-32. PubMed ID: 24398439
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.
Wang LW; Yang SH; Lin JK; Lin TC; Chan WK; Chen WS; Wang HS; Jiang JK; Lee RC; Li AF; Chao Y; Chi KH; Yen SH
J Surg Oncol; 2005 Mar; 89(4):256-63; discussion 263-4. PubMed ID: 15726610
[TBL] [Abstract][Full Text] [Related]
19. Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension.
Huang PW; Lin CY; Lee LY; Hsieh CH; Hsu CL; Liau CT; Fan KH; Huang SF; Liao CT; Chang TC; Wang HM
Front Oncol; 2022; 12():866890. PubMed ID: 36249049
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer.
Hsieh MY; Chen G; Chang DC; Chien SY; Chen MK
Ann Surg Oncol; 2018 Jul; 25(7):2091-2097. PubMed ID: 29721725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
